These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6241855)

  • 41. [Immunocorrective therapy of rheumatoid arthritis by means of lymphocytoplasmopheresis].
    Miterev IuG; Nasonova VA; Dubrovina NA; Khotinian RI; Speranskiĭ AI
    Sov Med; 1982; (5):70-5. PubMed ID: 6981213
    [No Abstract]   [Full Text] [Related]  

  • 42. Studies in the pathogenesis of rheumatoid arthritis. 2: Antigen/antibody reactions with avascular joint tissues.
    Cooke TD; Scudamore RA
    Br J Rheumatol; 1989 Aug; 28(4):333-40. PubMed ID: 2663112
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cellular immunity in rheumatoid arthritis].
    Mathieu A; Pala R; Nurchis P; Garau P; Cauli A; Uras L
    Clin Ter; 1991 Dec 15-31; 139(5-6):209-17. PubMed ID: 1839372
    [No Abstract]   [Full Text] [Related]  

  • 44. The influence of chrysotherapy on T-lymphocyte subpopulations in rheumatoid arthritis.
    Pfreundschuh M; Parino G; Gram N; Bröker A; Gause A; Hunstein W
    Z Rheumatol; 1983; 42(6):328-31. PubMed ID: 6229937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of T cells in rheumatoid arthritis: new subsets and new targets.
    Toh ML; Miossec P
    Curr Opin Rheumatol; 2007 May; 19(3):284-8. PubMed ID: 17414957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Joint destruction in rheumatoid arthritis: biological bases.
    Kingsley G; Panayi GS
    Clin Exp Rheumatol; 1997; 15 Suppl 17():S3-14. PubMed ID: 9266128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Molecular mechanism of bone destruction].
    Inoue H; Takayanagi H
    Clin Calcium; 2009 Mar; 19(3):339-46. PubMed ID: 19252243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Modulation of immunocompetent cells in the synovial fluid TGF-beta].
    Kekow J; Gross WL; Carson DA; Lotz M
    Immun Infekt; 1991 Apr; 19(2):60-1. PubMed ID: 1677345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Osteoclast differentiation and activation].
    Takayanagi H
    Clin Calcium; 2007 Apr; 17(4):484-92. PubMed ID: 17404476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced T helper cell function for the spontaneous production of IgM rheumatoid factor in vitro in rheumatoid arthritis.
    Patel V; Panayi GS
    Clin Exp Immunol; 1984 Jun; 56(3):584-92. PubMed ID: 6235068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autocytotoxic cells in rheumatoid synovial fluids.
    Sugiyama E; Suzuki H; Yano S
    J Rheumatol; 1989 Mar; 16(3):276-9. PubMed ID: 2524590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Why do we not have a cure for rheumatoid arthritis?
    El-Gabalawy HD; Lipsky PE
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S297-301. PubMed ID: 12110149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T peripheral helper cells signature genes in patients with rheumatoid arthritis.
    Inamo J
    Clin Rheumatol; 2020 Jun; 39(6):2019-2021. PubMed ID: 32236900
    [No Abstract]   [Full Text] [Related]  

  • 54. The current status of therapeutic apheresis in the management of rheumatoid arthritis.
    Wallace DJ; Goldfinger D; Klinenberg JR
    Prog Clin Biol Res; 1982; 106():27-32. PubMed ID: 6757943
    [No Abstract]   [Full Text] [Related]  

  • 55. Leukapheresis in rheumatoid arthritis. Association of clinical improvement with reversal of anergy.
    Wahl SM; Wilder RL; Katona IM; Wahl LM; Allen JB; Scher I; Decker JL
    Arthritis Rheum; 1983 Sep; 26(9):1076-84. PubMed ID: 6615562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunotherapy of rheumatoid arthritis.
    Watts RA; Isaacs JD
    Ann Rheum Dis; 1992 May; 51(5):577-9. PubMed ID: 1535492
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunoregulatory changes in autoimmune disease.
    Veys EM; Hermanns P; Verbruggen G; Mielants H
    Diagn Immunol; 1983; 1(3):224-32. PubMed ID: 6238752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis.
    Frey O; Meisel J; Hutloff A; Bonhagen K; Bruns L; Kroczek RA; Morawietz L; Kamradt T
    Ann Rheum Dis; 2010 Aug; 69(8):1495-501. PubMed ID: 20498202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An immunohistological study of CD4+ lymphocyte subsets within inflammatory lesions with special reference to rheumatoid arthritis and inflammatory bowel disease.
    Moore K; Walters MT; Jones DB; Garvey E; Harvey J; Cawley MI; Smith JL
    Immunology; 1988 Nov; 65(3):457-63. PubMed ID: 2974833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cellular immunity in chronic polyarthritis: the effect of basic therapy on T-lymphocyte subpopulations].
    Rosenthal M; Sendelova S
    Schweiz Med Wochenschr; 1983 Mar; 113(11):394-8. PubMed ID: 6221406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.